Therefore, we aimed to (1) verify the immunohistochemical results obtained by Mei et al. [36], (2) analyze BRMS1 mRNA expression in gliomas of different WHO grades, and (3) examine the potential correlation of BRMS1 mRNA expression and tumor recurrence, multifocal/unifocal tumor growth, molecular characteristics, outcome, etc. employing our data and bioinformatic analyses of publicly available databases. This evidence concerns the gene BRMS1 and glioma.